Related references
Note: Only part of the references are listed.Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia
David P. Steensma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Michael Auerbach et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
J. Douglas Rizzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
Paolo Pronzato et al.
ONCOLOGIST (2010)
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Marcello Tonelli et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study
Heinz Ludwig et al.
EUROPEAN JOURNAL OF CANCER (2009)
Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia
Heinz Ludwig et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
The role of iron supplementation during epoietin treatment for cancer-related anemia
M. Hedenus et al.
MEDICAL ONCOLOGY (2009)
Anemia Management in Oncology and Hematology
Jerry L. Spivak et al.
ONCOLOGIST (2009)
Update on Erythropoiesis-Stimulating Agents and Clinical Trials in Oncology
Matti Aapro et al.
ONCOLOGIST (2009)
Blood Transfusion Promotes Cancer Progression: A Critical Role for Aged Erythrocytes
Shir Atzil et al.
ANESTHESIOLOGY (2008)
Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer
Alok A. Khorana et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer:: an updated meta-analysis of 12 randomised controlled studies including 2301 patients
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2008)
Erythropoietin in cancer-related anemia
Martin H. Fenner et al.
CURRENT OPINION IN ONCOLOGY (2008)
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
Gillian Thomas et al.
GYNECOLOGIC ONCOLOGY (2008)
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
H. -G. Strauss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Laurent Bastit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa
Paolo Pedrazzoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue
Ollie Minton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Erythropoiesis-stimulating agents: Favorable safety profile when used as indicated
Mohammad R. Nowrousian et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9
Jaroslav Truksa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy
Adam S. Kader et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Risks and benefits of erythropoiesis-stimulating agents in cancer management
Gernot Beutel et al.
SEMINARS IN HEMATOLOGY (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer:: 2006 update
C. Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2007)
Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp (R)) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial
J. Overgaard et al.
EJC SUPPLEMENTS (2007)
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
David H. Henry et al.
ONCOLOGIST (2007)
Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy - A secondary analysis of three consecutive clinical phase III trials
K. -L. Zhao et al.
CLINICAL ONCOLOGY (2006)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease
Igor Theurl et al.
BLOOD (2006)
Update on adverse drug events associated with parenteral iron
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review
GH Lyman et al.
CANCER (2006)
Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis
J Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia
P Vaupel et al.
ONKOLOGIE (2005)
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
M Auerbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Treatment of cancer-related anemia with epoetin alfa: a review
E Ferrario et al.
CANCER TREATMENT REVIEWS (2004)
Management of anemia in patients undergoing curative radiotherapy - Erythropoietin, transfusions, or better nothing?
J Dunst
STRAHLENTHERAPIE UND ONKOLOGIE (2004)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
C Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2004)
The European Cancer Anaemia Survey (ECAS):: A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
H Ludwig et al.
EUROPEAN JOURNAL OF CANCER (2004)
Medical staff attitudes: Views and positions regarding blood transfusion to terminally ill cancer patients
A Leibovitz et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Erythropoietin, uncertainty principle and cancer related anaemia
O Clark et al.
BMC CANCER (2002)
Anemia, hypoxia and transfusion in patients with cervix cancer: a review
AW Fyles et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
PJ Barrett-Lee et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
